- Home
- HRMY vs HTZ Comparison
HRMY vs HTZ Comparison
Compare HRMY & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- HTZ
- Stock Information
- Founded
- HRMY 2017
- HTZ 1918
- Country
- HRMY United States
- HTZ United States
- Employees
- HRMY N/A
- HTZ N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- HTZ Rental/Leasing Companies
- Sector
- HRMY Health Care
- HTZ Consumer Discretionary
- Exchange
- HRMY Nasdaq
- HTZ Nasdaq
- Market Cap
- HRMY 1.8B
- HTZ 2.0B
- IPO Year
- HRMY 2020
- HTZ 1997
- Fundamental
- Price
- HRMY $34.00
- HTZ $7.54
- Analyst Decision
- HRMY Strong Buy
- HTZ Sell
- Analyst Count
- HRMY 9
- HTZ 8
- Target Price
- HRMY $54.44
- HTZ $4.45
- AVG Volume (30 Days)
- HRMY 642.5K
- HTZ 7.7M
- Earning Date
- HRMY 08-05-2025
- HTZ 08-07-2025
- Dividend Yield
- HRMY N/A
- HTZ N/A
- EPS Growth
- HRMY 13.13
- HTZ N/A
- EPS
- HRMY 2.62
- HTZ N/A
- Revenue
- HRMY $744,852,000.00
- HTZ $8,782,000,000.00
- Revenue This Year
- HRMY $20.10
- HTZ N/A
- Revenue Next Year
- HRMY $18.01
- HTZ $2.42
- P/E Ratio
- HRMY $13.10
- HTZ N/A
- Revenue Growth
- HRMY 20.62
- HTZ N/A
- 52 Week Low
- HRMY $26.47
- HTZ $2.47
- 52 Week High
- HRMY $41.61
- HTZ $9.39
- Technical
- Relative Strength Index (RSI)
- HRMY 58.91
- HTZ 59.18
- Support Level
- HRMY $31.70
- HTZ $6.95
- Resistance Level
- HRMY $35.08
- HTZ $8.44
- Average True Range (ATR)
- HRMY 0.95
- HTZ 0.57
- MACD
- HRMY 0.27
- HTZ 0.07
- Stochastic Oscillator
- HRMY 71.80
- HTZ 63.86
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About HTZ Hertz Global Holdings Inc
Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.